← Return to Oxybutynin superior to placebo in reducing ADT-associated hot flashes
DiscussionOxybutynin superior to placebo in reducing ADT-associated hot flashes
Prostate Cancer | Last Active: Feb 16 2:25pm | Replies (18)Comment receiving replies
Replies to "@jime51 A couple of people came into ancan.org and said that they were on oxybutynin For..."
Connect

@jeffmarc The urologist would have prescribed Venlafaxine if Myrbetriq were controlling nighttime urinary frequency. Since it hasn't, he's considering oxybutynin for both issues. Thanks for the additional resources!